ESH Video

3rd How to Diagnose and Treat Acute Leukaemias

3rd How to Diagnose and Treat Acute Leukaemias
March 11 - March 13, 2022 - Budapest, Hungary - #ESHAL2022
Chairs : Hervé Dombret, Gert J. Ossenkoppele, Jorge Sierra, Wendy Stock


ESH 3rd How to Diagnose and Treat:
Acute Leukaemias
March 11-13, 2022 – Budapest, Hungary


Chairs: Hervé Dombret, Gert Ossenkoppele, Jorge Sierra, Wendy Stock

About the Conference:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management which is greatly facilitated by and discussion of real clinical cases. An important incentive will be to promote interaction between the speakers and participants.

Novel and still evolving insights into the biology and diagnosis of acute leukaemias, including acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease.

The programme of this “3rd How to Diagnose and Treat: Acute Leukaemia” meeting will integrate of genomic analysis and cutting-edge technics in routine diagnosis, gene mutation-directed therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes.

This meeting will be valuable for you if you are looking for:
• A high-quality scientific programme – from basic science to clinical and therapeutic applications together a glimpse in the future
• Many opportunities for scientific interaction with an international faculty of distinguished leukemia experts
• Ample time for critical discussion
• The meeting will provide state-of-the-art recommendations regarding patient care and insights into controversies and new therapeutic perspectives in the field.

This meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior biologists and clinicians (MD, PhD)
• Clinical residents still in-training
• Allied health care professionals

Learning objectives:
• Get knowledge of diagnostic tests needed to optimally manage patients with AML and ALL
• Get insight in new treatment strategies available for AML and ALL patients for front-line and for salvage therapy
• Maintenance treatment
• Understand the value of measurable residual disease (MRD) levels to direct acute leukaemia therapy
• Gain insight into emerging mechanisms associated with clinical resistance and leukaemia escape
• Understand the effects and place of new immunotherapies with respect to standard or new HSCT procedures

Topics :
• Diagnosis and rare diseases
• Measurable Residual Disease (MRD)
• Leukaemia treatment dilemmas
• Intensive chemotherapy for older fit patients
• MRD level before transplant
• Leukaemia treatment challenges
• Ph-positive ALL
• CAR-T cell for ALL patients
• Immune therapies to treat leukaemia patients
• Haematopoietic stem cell transplantation

The programme will include:
• Plenary Sessions
• Interactive Case Presentations
• Roundtables
• Panel Discussions
• Debates
• Meet the Expert Sessions
• Poster Walks
• Voting technology


Click here to access the preliminary programme.

Abstract submission

Deadline for abstracts and clinical cases: January 9th, 2022 (23:59 CET) 

Clinical Cases and abstracts are eligible to be selected for an oral or a poster presentation.

Click here to submit your abstract or your clinical case!


Clinical Case Presentation:

  • Clinical cases must be relevant to the topic of the meeting. 
  • Maximum number of words: 500 
  • Your clinical case will be submitted to peer review. 


  • Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured. 
  • Maximum number of words: 500 
  • Your abstract will be submitted to peer review.




Accommodation at special conference rates is available at the Marriott Budapest Hotel, where the conference will take place.

Click here to book your accommodation. 

Hotel(s) offering your special group rate:
Budapest Marriott Hotel for 180 EUR per night
Last Day to Book: Wednesday, February 9th, 2022


We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link(s) provided by ESH on this page, or directly with the hotel or renown booking services platform.


Budapest Marriott Hotel
Apáczai Csere János u. 4
Budapest 1052

Corporate partners

With the support of*:




Major Conference Partner


Level 1 Conference Partner




Level 2 Conference Partner



*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.



Educational Grants



The registration fee for the ESH 3rd How to Diagnose and Treat Acute Leukaemias is:
– 600€ for fully trained
– 300€ for in-training
– 300€ Allied Health Professionals
– 600€ for Corporate

*A proof will be requested to confirm your status.

This fee includes:
Your seat in the Conference Room
The conference materials,
Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

How to proceed :
Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

A) For Individual Registration:
1. Click on REGISTER HERE at the bottom of the page
3. Create an account and complete the registration form. It is very important to use the email of the participant in the form.
4. Proceed with the payment.

B) For Group Registration (More than one person):
1. Click on REGISTER HERE at the bottom of the page
3. Create an account and fill in the complete details for each person that you would like to register (Use the personal email address of each participant you are registering, failure to do so will prohibit you from completing the registrations.)
4. Proceed with payment.

Cancellation policy of registration fee
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA, MASTERCARD/EUROCARD, AMEX and CB.

Register Here